Omixon company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

About Omixon

Omixon is a global molecular diagnostics company that commercializes technologies for clinical and research laboratories. Omixon's flagship product, Holotype HLA, is an NGS-based HLA genotyping product that delivers high-resolution HLA genotyping. Omixon's research software, HLA Explore, analyzes data from any sequencing technology and determines HLA genotypes from whole exome/genome sequencing experiments.

Omixon Headquarter Location

Fehervari Ave. 50-52

Budapest, 1117,



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Omixon News

Omixon Picks up Option to Acquire Organ Monitoring Group

Jun 6, 2022

Save for later NEW YORK — Hungarian transplant diagnostics firm Omixon Biocomputing said last week that it has acquired an option to fully acquire Organ Monitoring Group as part of a product development alliance between the companies. According to Omixon, the partners are developing a cell-free DNA assay, called HoloGraft, that uses digital PCR to monitor copy number variant-based biomarkers for patient-specific responses to organ transplants. The assay is based on technology held exclusively for commercial applications by Organ Monitoring Group. As part of the collaboration, Omixon has the exclusive option to acquire the 50 percent of Organ Monitoring Group that it does not already own. Financial and other terms were not disclosed. "Frequent monitoring of transplant rejection can help to recognize rejection early when it can be treated without irreversible damage to the organ," Omixon CEO Attila Berces said in a statement. "HoloGraft … makes frequent transplant monitoring affordable." In late 2020, Omixon received  CE marking for an extraction-free viral RNA detection kit to detect SARS-CoV-2.

Omixon Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Omixon Rank

  • When was Omixon founded?

    Omixon was founded in 2012.

  • Where is Omixon's headquarters?

    Omixon's headquarters is located at Fehervari Ave. 50-52, Budapest.

  • What is Omixon's latest funding round?

    Omixon's latest funding round is Series A.

  • Who are the investors of Omixon?

    Investors of Omixon include Euroventures.

  • Who are Omixon's competitors?

    Competitors of Omixon include Sequentia Biotech.

You May Also Like


ACGT develops genomics-based solutions that increase productivity and enhance value creation from the oil palm and other oil crops. It is based in Kuala Lumpur, Malaysia.

Aperiomics Logo

Aperiomics identifies bacteria, viruses, fungi, and parasites through Deep Shotgun Metagenomic Sequencing, using its database of microbes. The company helps doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome.

Sequentia Biotech

Sequentia Biotech is a bioinformatics company that transforms omics data into knowledge. The company offers bioinformatics cloud softwares, custom softwares and bioinformatics consulting services for healthcare, pharma, agriculture, industry and the environment.

Stratos Genomics

Stratos Genomics is a biotechnology company that develops genome sequencing through the Sequencing by Expansion (SBX) method, a single-molecule detection process that circumvents the limitations of competing technologies.On June 1st, 2020 Stratos Genomics was acquired by Roche. The terms of the transaction were not disclosed.

CJ Bioscience Logo
CJ Bioscience

CJ Bioscience (KOSDAQ: 311690) is a bioinformatics company that develops data-driven microbiome therapeutics solutions for the microbiology sector. The company's suite of tools includes EzBioCloud, a database for academic research and commercial development, and BIOiPLUG, a cloud-based bioinformatics and analysis platform. It was founded in 2009 and is based in Seoul, South Korea.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.